Le Lézard
Classified in: Health

Working With Ethical Professionals Is Key To Adoption Success


GREENWOOD, Ind., Oct. 28, 2021 /PRNewswire-PRWeb/ -- Every day in the United States and abroad children are placed for adoption into loving homes. These adoptions take place legally and they are done ethically. Unfortunately, these are not usually the stories that make the press. Instead, stories like "How an Adoption Broker Cashed In on Prospective Parents' Dreams," recently published in The New Yorker, detailing events that never should have happened, are the adoption stories that the public most often hear.

The attorneys of the non-profit organization, the Academy of Adoption and Assisted Reproduction Attorneys ("AAAA"), are dedicated to minimizing the number of adoption stories that end like the one described in The New Yorker, with prospective parents being defrauded by corrupt agencies or facilitators. Committed to the competent and ethical practice of adoption law, AAAA and its attorneys or "Fellows" advocate for laws and policies to protect the best interests of children, the legal status of families formed through adoption, and the rights of all interested parties. AAAA Fellows apply the law and best legal practices and have successfully helped thousands of clients through their family building journey. AAAA Fellows also represent thousands of birth parents to assure they are treated fairly and with dignity as they make the difficult decision to place a child for adoption.

The Academy of Adoption and Assisted Reproduction Attorneys is represented by over 500 attorneys from the United States and abroad who specialize in adoption law, assisted reproductive technology law (ART) or both. AAAA provides a credentialed presence in the law of family formation and is the largest professional organization of its type dedicated to advancing the security of children through permanent adoption, the protection of children through safe and secure foster care with appropriate permanency planning, and the recognition of intended parents as legal parents for those using modern medical technology to build families through assisted reproductive technology.

Admission to AAAA is a selective process that requires no less than five years of legal practice, at least 50 diverse adoption or assisted reproductive technology proceedings, a referral for admission by a current AAAA member, and rigorous review for high ethical standards and competency by the board of directors.

AAAA is committed to the finest in legal practice and to serving the adoption triad ? children, birth families and adoptive families ? with compassion and competency. While AAAA supports the exposure of unethical adoption practices in the press to educate the public, AAAA reminds all that ethical and competent adoption professionals should be highlighted and promoted to encourage the public to seek out those of the highest standards to assist in their adoption journey.

AAAA is headquartered in Greenwood, Indiana. For more information, visit us at adoptionART.org.

Media Contact

Genie Miller Gillespie, Academy of Adoption & Assisted Reproduction Attorneys, (312) 332-6339, president@adoptionart.org

Twitter

 

SOURCE Academy of Adoption & Assisted Reproduction Attorneys


These press releases may also interest you

at 07:15
Aurora Spine Corporation ("Aurora Spine" or the "Company") , a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has retained PRIA Healthcare to assist in patient access for its...

at 07:15
The Breast Cancer Society of Canada, (BCSC) launches call for Breast Cancer Research Proposals, 2022.   Thanks to the generous...

at 07:15
Fibromyalgia Care Society of America (FCSA) launched the nation's first ever virtual coordinated care program, under their Center of Excellence Program, to empower and equip individuals living with fibromyalgia through online treatment access to...

at 07:10
IMV Inc. , a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPXtm platform to treat solid and blood cancers, today announced new translational data implicating B cells in the clinical benefit induced by...

at 07:05
ZZ Biotech, a clinical stage biopharmaceutical company developing the experimental drug 3K3A-APC for some of the biggest unmet needs in stroke, neurodegenerative disease and chronic wound healing, today announced that the first patients have been...

at 07:05
ELNA Medical ("ELNA"), the largest network of primary and specialty care clinics in Canada, is pleased to announce two additional key management appointments to support and accelerate its growth strategy across Canada. In these newly created...



News published on 28 october 2021 at 08:00 and distributed by: